Loading...
Vynleads, Inc.
VYND•PNK
Healthcare
Medical - Healthcare Information Services
$0.50
$0.00(0.00%)
Vynleads, Inc. (VYND) Financial Performance & Income Statement Overview
Review Vynleads, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-1.49%
↓ 1.49%
Net Income Growth
0.85%
↑ 0.85%
Operating Cash Flow Growth
22.37%
↑ 22.37%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
47.55%
↑ 47.55%
ROIC
88.92%
↑ 88.92%
Vynleads, Inc. (VYND) Income Statement & Financial Overview
Review Vynleads, Inc.'s (VYND) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Cost of Revenue | $4718.00 | $5235.00 | $788.00 | $4636.00 |
Gross Profit | -$4718.00 | -$5235.00 | -$788.00 | -$4636.00 |
Gross Profit Ratio | ||||
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $75313.00 | $52652.00 | $50617.00 | $51321.00 |
Operating Expenses | $75313.00 | $52652.00 | $50617.00 | $51321.00 |
Total Costs & Expenses | $80031.00 | $57887.00 | $51405.00 | $55957.00 |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | -$939.00 | $3146.00 | $7253.00 | $7030.00 |
Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $4716.00 |
EBITDA | -$80031.00 | -$57886.00 | -$51405.00 | -$51241.00 |
EBITDA Ratio | ||||
Operating Income | -$80031.00 | -$57887.00 | -$51405.00 | -$55957.00 |
Operating Income Ratio | ||||
Other Income/Expenses (Net) | -$939.00 | -$3145.00 | -$7253.00 | -$2314.00 |
Income Before Tax | -$80970.00 | -$61032.00 | -$58658.00 | -$58271.00 |
Income Before Tax Ratio | ||||
Income Tax Expense | $0.00 | $2615.00 | $0.00 | $0.00 |
Net Income | -$80970.00 | -$63647.00 | -$58658.00 | -$58271.00 |
Net Income Ratio | ||||
EPS | -$0.004 | -$0.005 | -$0.005 | -$0.005 |
Diluted EPS | -$0.004 | -$0.005 | -$0.005 | -$0.005 |
Weighted Avg Shares Outstanding | $18.33M | $18.33M | $11.70M | $11.60M |
Weighted Avg Shares Outstanding (Diluted) | $18.33M | $18.33M | $11.70M | $11.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan